Showing 181 - 200 results of 229,029 for search '(( a point decrease ) OR ( 10 ((((teer decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.81s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189
  10. 190

    Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells. by Malgorzata Borkowska (3166719)

    Published 2016
    “…<p>(<b>A</b>) Significant decreases in the proportions of PV+ cells were observed in fSSp, SSp, vAud and in Vis, but not MPFC. …”
  11. 191

    Mean amplitude values during a complete 360° rotation for the iliocostalis muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  12. 192

    Mean amplitude values during a complete 360° rotation for the longissimus muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  13. 193

    Mean amplitude values during a complete 360° rotation for the multifidus muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  14. 194

    Theoretical relative decrease in oxygen consumption of R3230Ac cells as a function of MKT-077 uptake. by John L. Chunta (164912)

    Published 2012
    “…<p>R3230Ac cells were treated with 2, 4, or 6 µg/ml MKT-077 at t = 0 minutes. Percent decrease in consumption, %Δq, was calculated from Equation 26 using the mean fitted parameters (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0037471#pone-0037471-t003" target="_blank">Table 3</a>). …”
  15. 195
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”